A significant upgrade from a major investment bank has cast a new light on International Business Machines Corp. (IBM), suggesting its multi-year transformation under CEO Arvind Krishna is beginning to bear fruit. The move signals growing confidence that the technology giant’s sharpened focus on software and hybrid cloud solutions is closing a perceived valuation gap with its peers.
Analyst Upgrade Highlights Valuation Discrepancy
In a notable shift in sentiment, analysts at Jefferies raised their rating on IBM shares from “Hold” to “Buy” on January 5. The firm also substantially increased its price target, moving it from $300 to $360 per share. Lead analyst Brent Thill cited a clearer trajectory toward accelerated software growth as the primary rationale for the upgrade.
Central to Jefferies’ analysis is a compelling valuation argument. IBM is currently trading at a forward price-to-earnings (P/E) ratio of approximately 26 for the year 2027. This stands in contrast to the average multiple of 35 commanded by comparable large-cap software companies. According to the bank, this discrepancy indicates substantial room for upward re-rating, provided IBM successfully capitalizes on synergies from its Red Hat subsidiary and recent strategic acquisitions. The market responded favorably to the upgrade, with shares closing the week at $304.22, marking a weekly gain of over 3%.
Strategic Acquisitions Fuel the Transformation
IBM’s management is actively executing its expansion strategy. A key component is the planned all-cash acquisition of data-streaming specialist Confluent for $11 billion, which is expected to be finalized by mid-2026. This deal holds high strategic importance. Confluent’s technology, built on the open-source Apache Kafka platform, facilitates the real-time processing of massive data streams—infrastructure considered critical for powering modern artificial intelligence (AI) applications.
Should investors sell immediately? Or is it worth buying IBM?
IBM estimates that the total addressable market for such solutions doubled between 2021 and 2025, reaching $100 billion. Financially, the transaction is projected to contribute positively to adjusted EBITDA within the first full year following its completion.
This move follows the company’s acquisition of HashiCorp for $6.4 billion, which was finalized in February 2025. The Confluent deal represents IBM’s largest acquisition since its landmark purchase of Red Hat in 2019. Under Krishna’s leadership, the company has consistently pursued targets in the hybrid cloud and software domains to reduce its historical reliance on legacy hardware businesses.
Focus on Recurring Software Revenue and AI
The strategic direction is unambiguous: to increase the proportion of high-margin, recurring software revenue. In its 2026 sector outlook, Jefferies identified this shift as IBM’s core strength, positioning the company to benefit significantly from the growing monetization of AI applications in enterprise environments.
Forthcoming Earnings to Provide Integration Clues
Investors will soon gain more concrete insights into the progress of these strategic integrations. IBM is scheduled to release its fourth-quarter 2025 financial results on January 28, 2026. Market participants will likely scrutinize the report for any updates on the Confluent acquisition timeline and further commentary on the anticipated synergy effects from recent purchases.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from January 11 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 11.
IBM: Buy or sell? Read more here...
